Related Experiment Video

Updated: Jun 1, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Clinical response to statins: mechanism(s) of variable activity and adverse effects

Cesare R Sirtori1, Giuliana Mombelli, Michela Triolo

  • 1Dyslipidemia Center, Niguarda Hospital, Milan, Italy. cesare.sirtori@unimi.it

Annals of Medicine
|June 1, 2011
PubMed

Insights

Genetic factors influence how well statins lower cholesterol and cause side effects like myopathy. Understanding how the body processes statins, especially through transporters like OATP1B1, is key to improving treatment effectiveness and safety.

Area of Science:

  • Pharmacogenetics
  • Molecular Pharmacology
  • Cardiovascular Medicine

Background:

  • Statins are crucial for treating hypercholesterolemia, a major atherosclerosis risk factor.
  • Significant inter-individual variability exists in statin response and side effects like myopathy.
  • The roles of cytochrome P450 (CYP) and membrane transporters in statin metabolism are not fully understood.

Purpose of the Study:

  • To explore the genetic factors influencing statin efficacy and toxicity.
  • To elucidate the mechanisms of statin handling by cytochrome P450 enzymes and membrane transporters.
  • To identify genetic polymorphisms associated with variable statin responses and adverse effects.

Main Methods:

  • Review of existing literature on statin metabolism and pharmacogenetics.
  • Analysis of the roles of cytochrome P450 (CYP) enzymes, particularly CYP3A4.
  • Investigation of the involvement of organic anion-transporting polypeptide 1B1 (OATP1B1) and its encoding gene (SLCO1B1).

Main Results:

  • CYP polymorphisms can affect statin hypolipidemic activity.
  • CYP inhibitors can alter statin plasma concentrations, with variable clinical outcomes.
  • Pravastatin and rosuvastatin are OATP1B1 substrates; SLCO1B1 polymorphisms impact liver uptake, therapeutic potential, and myopathy risk.

Conclusions:

  • Genetic variations, particularly in SLCO1B1, significantly influence statin effectiveness and safety.
  • Understanding statin transport mechanisms is vital for personalized medicine.
  • Targeting transporter pathways can help minimize adverse effects and enhance lipid-lowering efficacy.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...